Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE We retrospectively examined pretreatment F-FDG PET/CT images obtained from 85 patients with nonmetastatic SGC showing high-risk histology. 30932974

2019

Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE The texture analysis of pretreatment [<sup>18</sup>F]FDG PET/CT provided more information than conventional PET parameters for predicting patient prognosis of locally advanced salivary gland carcinoma treated with interstitial brachytherapy. 31511990

2019

Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE Up-front F18-FDG PET/CT in suspected salivary gland carcinoma. 31102059

2019

Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE We conducted a 2-center, retrospective study on 117 patients with salivary gland carcinoma who underwent F-FDG PET/CT before treatment and were subsequently treated with curative intent between 2004 and 2014. 30273205

2018

Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE The aim of this study was to investigate the prognostic significance of F-FDG uptake in salivary gland carcinoma (SGC) patients treated with definitive intensity-modulated radiation therapy (IMRT). 28650891

2017

Entrez Id: 1956
Gene Symbol: EGFR
EGFR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE Patients with pN-positive salivary gland cancer may benefit from EGFR-inhibiting drugs. 26245271

2016

Entrez Id: 1956
Gene Symbol: EGFR
EGFR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer. 23242174

2013

Entrez Id: 1956
Gene Symbol: EGFR
EGFR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 AlteredExpression BEFREE Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. 22240798

2012

Entrez Id: 1956
Gene Symbol: EGFR
EGFR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 Biomarker BEFREE Overall, overexpression and increased gene copy number of EGFR and HER2 characterize high-grade malignancy with unfavorable prognosis in salivary gland cancer. 22154363

2012

Entrez Id: 1956
Gene Symbol: EGFR
EGFR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.050 GeneticVariation BEFREE Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma. 18542074

2008

Entrez Id: 367
Gene Symbol: AR
AR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.040 Biomarker BEFREE First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. 31428578

2019

Entrez Id: 367
Gene Symbol: AR
AR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.040 Biomarker BEFREE Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target. 29863801

2018

Entrez Id: 367
Gene Symbol: AR
AR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.040 Biomarker BEFREE We conducted a single institution, open-label, single arm, phase II trial of combined androgen blockade (CAB) for androgen receptor (AR)-positive SGC. 29211833

2018

Entrez Id: 367
Gene Symbol: AR
AR
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.040 Biomarker BEFREE In this review, we describe the prevalence, biology, and therapeutic implications of androgen receptor signaling in salivary gland cancer. 28208703

2017

Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.030 Biomarker BEFREE Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature. 28006087

2017

Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.030 Biomarker BEFREE Overall, overexpression and increased gene copy number of EGFR and HER2 characterize high-grade malignancy with unfavorable prognosis in salivary gland cancer. 22154363

2012

Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.030 AlteredExpression BEFREE Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. 22240798

2012

Entrez Id: 8848
Gene Symbol: TSC22D1
TSC22D1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.030 Biomarker BEFREE Separately, we identified TSC-22 cDNA as an anti-cancer drug (vesnarinone)-inducible gene in a human salivary gland cancer cell line, TYS. 15379637

2004

Entrez Id: 8848
Gene Symbol: TSC22D1
TSC22D1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.030 AlteredExpression BEFREE Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. 10879745

2000

Entrez Id: 8848
Gene Symbol: TSC22D1
TSC22D1
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.030 AlteredExpression BEFREE Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. 9458104

1998

Entrez Id: 29126
Gene Symbol: CD274
CD274
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.020 Biomarker BEFREE Objective was to analyze the role of PD-L1 and its relation to demographic, patho-clinical and outcome parameters in salivary gland carcinoma (SGC) patients. 31484986

2019

Entrez Id: 10534
Gene Symbol: ZNRD2
ZNRD2
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.020 Biomarker BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867

2019

Entrez Id: 353376
Gene Symbol: TICAM2
TICAM2
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.020 Biomarker BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867

2019

Entrez Id: 51014
Gene Symbol: TMED7
TMED7
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.020 Biomarker BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867

2019

Entrez Id: 100302736
Gene Symbol: TMED7-TICAM2
TMED7-TICAM2
CUI: C0948750
Disease: Salivary gland carcinoma
Salivary gland carcinoma
0.020 Biomarker BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867

2019